Chemical Compound

Rosuvastatin Calcium Imp. D (EP); Rosuvastatin Imp. D (EP); Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-; Rosuvastatin lactone; Rosuvastatin-5S-lactone; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide; Rosuvastatin Calcium Impurity D; Rosuvastatin Impurity D

CAS Registry Number 503610-43-3
Rosuvastatin Calcium Imp. D (EP); Rosuvastatin Imp. D (EP); Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-; Rosuvastatin lactone; Rosuvastatin-5S-lactone; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide; Rosuvastatin Calcium Impurity D; Rosuvastatin Impurity D 结构式
Primary record

Rosuvastatin Calcium Imp. D (EP); Rosuvastatin Imp. D (EP); Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-; Rosuvastatin lactone; Rosuvastatin-5S-lactone; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide; Rosuvastatin Calcium Impurity D; Rosuvastatin Impurity D

库存
2,809 克
纯度
98.1 %
CAS
503610-43-3

化合物标识与属性

CAS
503610-43-3
PubChem CID
29918986
SMILES
CC(C)C1=NC(=NC(=C1/C=C/[C@@H]2C[C@H](CC(=O)O2)O)C3=CC=C(C=C3)F)N(C)S(=O)(=O)C
Canonical SMILES
CC(C)c1nc(N(C)S(C)(=O)=O)nc(-c2ccc(F)cc2)c1/C=C/[C@@H]1C[C@@H](O)CC(=O)O1

名称与同义词

  • Rosuvastatin Lactone
  • Rosuvastatin-5S-lactone
  • 503610-43-3
  • Rosuvastatin EP Impurity D
  • ent-Rosuvastatin Lactone
  • RefChem:179941
  • FL37W41F3T
  • Rosuvastatin 5 S-lactone
  • Rosuvastatin-5-S-lactone
  • UNII-FL37W41F3T
  • SCHEMBL245091
  • C22H26FN3O5S
  • DTXSID901034473
  • orb1740302
  • SCHEMBL30571404
  • CHEBI:184522
  • SOEGVMSNJOCVHT-VEUZHWNKSA-N
  • DTXCID401519038
  • Rosuvastatin Calcium EP Impurity D
  • ZINC21981364
  • AKOS015896316
  • CS-O-10334
  • FR27761
  • ROSUVASTATIN-5S-LACTONE IMPURITY
  • AC-30584
  • AS-82903
  • BC657646
  • N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide
  • SC-23229
  • ROSUVASTATIN LACTONE [USP IMPURITY]
  • HY-138166
  • RT-015445
  • CS-0145597
  • J2.810.552E
  • A24858
  • F19301
  • 610R433
  • I06-2029
  • ROSUVASTATIN CALCIUM IMPURITY D [EP IMPURITY]
  • Methanesulfonamide, N-(4-(4-fluorophenyl)-6-(1-methylethyl)-5-((1E)-2-((2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethenyl)-2-pyrimidinyl)-N-methyl-
  • N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulfonamide
  • B0194-069823
  • N-(4-(4-fluorophenyl)-5-((E)-2-((2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)vinyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
  • N-[4-(4-fluorophenyl)-5-[(1E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-(propan-2-yl)pyrimidin-2-yl]-N-methylmethanesulfonamide
  • 1797419-58-9
  • N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide
  • (3R,5S,6E)-3,5-Dihydroxy-7-[2-[methyl(methylsulfonyl)amino]-4-(4-fluorophenyl)-6-isopropylpyrimidine-5-yl]-6-heptenoic acid 1,5-lactone
  • 615263-62-2
  • 836-302-1
  • E-6-{2-[2-(N-methyl-N-methanesulfonylamino)-4-(4-fluorophenyl)-6-isopropyl-pyrimidin-5-yl]vinyl}-(4R,6S)-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
  • Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2R,4S)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-, rel-; ent-Rosuvastatin Lactone; Rosuvastatin-5R-lactone; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2SR,4RS)-4
  • N-(4-(4-FLUOROPHENYL)-6-(1-METHYLETHYL)-5-((1E)-2-((2S,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHENYL)-2-PYRIMIDINYL)-N-METHYLMETHANESULFONAMIDE
  • N-[4-(4-fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]vinyl]-6-isopropyl-pyrimidin-2-yl]-N-methyl-methanesulfonamide
  • N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide (Rosuvastatin Lactone)
  • N-[4-(4-luorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxooxan-2-yl]ethenyl]-6-propan-2-ylpyrimidin-2-yl]-N-methylmethanesulonamide
  • N-[4-(4-N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]- N-methyl-methanesulfonamide
  • Rosuvastatin Calcium Imp. D (EP); Rosuvastatin Imp. D (EP); Methanesulfonamide, N-[4-(4-fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methyl-; Rosuvastatin lactone; Rosuvastatin-5S-lactone; N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide; N-[4-(4-Fluorophenyl)-5-[(E)-2-[(2S,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethenyl]-6-(1-methylethyl)pyrimidin-2-yl]-N-methylmethanesulfonamide; Rosuvastatin Calcium Impurity D; Rosuvastatin Impurity D